Skip to main content

Table 1 Baseline characteristics according to body mass index (n = 643)

From: Impact of Body Mass Index on the relationship of epicardial adipose tissue to metabolic syndrome and coronary artery disease in an Asian population

Characteristics

BMI < 27 kg/m2

(n = 478)

BMI ≥ 27 kg/m2

(n = 165)

p

Male, No

252 (53%)

80 (48%)

NS

Age (year-old)

59 ± 11

59 ± 11

NS

EAT thickness (mm)

   

   Mean ± SD

3.0 ± 2.4

3.5 ± 2.4

0.01

   Median

2.8

3.0

0.01

Body Mass Index (kg/m2)

23.7 ± 2.4

29.0 ± 2.1

< 0.001

Waist circumference (cm)

   

   Male

87.0 ± 8.0

97.1 ± 7.5

< 0.001

   Female

84.7 ± 9.1

95.0 ± 7.6

< 0.001

Total cholesterol (mg/dl)

170.6 ± 35.3

182.32 ± 39.2

0.001

LDL cholesterol (mg/dl)

97.0 ± 30.0

104.4 ± 33.7

0.025

Triglyceride (mg/dl)

142.1 ± 83.3

183.1 ± 109.5

< 0.001

HDL cholesterol (mg/dl)

   

   Male

44.0 ± 10.7

40.3 ± 9.2

0.013

   Female

48.3 ± 12.7

47.1 ± 11.3

NS

Fasting glucose (mg/dl)

115.0 ± 33.9

120.0 ± 43.4

NS

Hypertension, No

313 (66%)

125 (76%)

0.012

Diabetes, No

295 (62%)

128 (78%)

< 0.001

Smoking, No

156 (33%)

41 (25%)

0.048

Metabolic Syndrome, No

243 (49%)

133 (81%)

< 0.001

Metabolic Score

2.5 ± 1.3

3.3 ± 1.0

< 0.001

Coronary Artery Disease, No

247 (52%)

74 (45%)

NS

   Normal & minimal CAD

230 (48%)

91 (55%)

NS

   1 vessel

111 (23%)

31 (19%)

NS

   2 vessel

69 (14%)

24 (15%)

NS

   3 vessel

65 (14%)

19 (12%)

NS

Medication, No

   

   Aspirin

115 (24%)

37(22%)

NS

   Beta blockers

49 (10%)

19 (12%)

NS

   Calcium channel blockers

89 (19%)

33 (20%)

NS

   ACE inhibitors

23 (5%)

4 (2%)

NS

   AT II receptor blockers

58 (12%)

22 (13%)

NS

   Statins

46 (10%)

22 (13%)

NS

   Nitrates

51 (11%)

16 (10%)

NS

   Diuretics

46 (10%)

18 (11%)

NS

  1. EAT, epicardial adipose tissue; LDL, low-density lipoprotein; HDL, high-density lipoprotein; CAD, coronary artery disease; ACE, angiotensin converting enzyme; AT, angiotensin; SD, standard deviation; NS, not significant